🇺🇸 FDA
Patent

US 9903855

Assays for screening for or identifying an agent or molecule that can block or inhibit AVB3 integrin from forming a complex with KRAS

granted A61KA61K31/337A61K31/437

Quick answer

US patent 9903855 (Assays for screening for or identifying an agent or molecule that can block or inhibit AVB3 integrin from forming a complex with KRAS) held by The Regents of the University of California expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/337, A61K31/437, A61K31/454, A61K31/496